BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28882442)

  • 1. Polio immunity and the impact of mass immunization campaigns in the Democratic Republic of the Congo.
    Voorman A; Hoff NA; Doshi RH; Alfonso V; Mukadi P; Muyembe-Tamfum JJ; Wemakoy EO; Bwaka A; Weldon W; Gerber S; Rimoin AW
    Vaccine; 2017 Oct; 35(42):5693-5699. PubMed ID: 28882442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Circulating vaccine-derived poliovirus type 2 outbreak in Democratic Republic of Congo 2011-2012].
    Bazira L; Coulibaly T; Mayenga M; Ncharre C; Yogolelo R; Mbule A; Moudzeo H; Lwamba P; Mulumba AW; Cabore J
    Bull Soc Pathol Exot; 2015 Oct; 108(4):235-41. PubMed ID: 26288132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poliovirus immunity among adults in the Democratic Republic of the Congo: a cross-sectional serosurvey.
    Alfonso VH; Voorman A; Hoff NA; Weldon WC; Gerber S; Gadoth A; Halbrook M; Goldsmith A; Mukadi P; Doshi RH; Ngoie-Mwamba G; Fuller TL; Okitolonda-Wemakoy E; Muyembe-Tamfum JJ; Rimoin AW
    BMC Infect Dis; 2022 Jan; 22(1):30. PubMed ID: 34986786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine-derived poliovirus serotype 2 outbreaks and response in the Democratic Republic of the Congo, 2017-2021.
    Alleman MM; Jorba J; Riziki Y; Henderson E; Mwehu A; Seakamela L; Howard W; Kadiobo Mbule A; Nsamba RN; Djawe K; Yapi MD; Mengouo MN; Gumede N; Ndoutabe M; Kfutwah AKW; Senouci K; Burns CC
    Vaccine; 2023 Apr; 41 Suppl 1(Suppl 1):A35-A47. PubMed ID: 36907733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass vaccination campaigns to eradicate poliomyelitis in Madagascar: oral poliovirus vaccine increased immunity of children who missed routine programme.
    Andrianarivelo MR; Boisier P; Rabarijaona L; Ratsitorahina M; Migliani R; Zeller H
    Trop Med Int Health; 2001 Dec; 6(12):1032-9. PubMed ID: 11737841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased immunogenicity of oral poliovirus vaccine administered in mass vaccination campaigns compared with the routine vaccination program in Jordan.
    Reichler MR; Kharabsheh S; Rhodes P; Otoum H; Bloch S; Majid MA; Pallansch MA; Patriarca PA; Cochi SL
    J Infect Dis; 1997 Feb; 175 Suppl 1():S198-204. PubMed ID: 9203717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors contributing to outbreaks of wild poliovirus type 1 infection involving persons aged ≥15 years in the Democratic Republic of the Congo, 2010-2011, informed by a pre-outbreak poliovirus immunity assessment.
    Alleman MM; Wannemuehler KA; Weldon WC; Kabuayi JP; Ekofo F; Edidi S; Mulumba A; Mbule A; Ntumbannji RN; Coulibaly T; Abiola N; Mpingulu M; Sidibe K; Oberste MS
    J Infect Dis; 2014 Nov; 210 Suppl 1():S62-73. PubMed ID: 25316879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robustness against serum neutralization of a poliovirus type 1 from a lethal epidemic of poliomyelitis in the Republic of Congo in 2010.
    Drexler JF; Grard G; Lukashev AN; Kozlovskaya LI; Böttcher S; Uslu G; Reimerink J; Gmyl AP; Taty-Taty R; Lekana-Douki SE; Nkoghe D; Eis-Hübinger AM; Diedrich S; Koopmans M; Leroy EM; Drosten C
    Proc Natl Acad Sci U S A; 2014 Sep; 111(35):12889-94. PubMed ID: 25136105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States.
    Chen RT; Hausinger S; Dajani AS; Hanfling M; Baughman AL; Pallansch MA; Patriarca PA
    JAMA; 1996 Jun; 275(21):1639-45. PubMed ID: 8637136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunity levels to poliovirus in Lao children and adults before the vaccine-derived poliovirus outbreak: A retrospective study.
    Pauly M; Black AP; Khampanisong P; Nouanthong P; Hübschen JM; Nanthavong N; Sayasinh K; Jutavijittum P; Samountry B; Xeuatvongsa A; Diedrich S; Muller CP
    PLoS One; 2018; 13(5):e0197370. PubMed ID: 29763458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress toward poliomyelitis eradication--Democratic Republic of Congo, 1996-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Mar; 49(12):253-8. PubMed ID: 10774546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine-derived polioviruses outbreaks and events in 3 provinces of Democratic Republic of the Congo, 2017.
    Wkly Epidemiol Rec; 2018 Mar; 93(11):117-25. PubMed ID: 29546749
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse events following immunization with oral poliovirus in Kinshasa, Democratic Republic of Congo: preliminary results.
    Nzolo D; Ntetani Aloni M; Mpiempie Ngamasata T; Mvete Luemba B; Bazundama Marfeza S; Bothale Ekila M; Ndosimao Nsibu C; Lutete Tona N
    Pathog Glob Health; 2013 Oct; 107(7):381-4. PubMed ID: 24392682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies.
    Mas Lago P; Ramon Bravo J; Andrus JK; Comellas MM; Galindo MA; de Quadros CA; Bell E
    Bull World Health Organ; 1994; 72(2):221-5. PubMed ID: 8205641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles seroprevalence after reactive vaccination campaigns during the 2015 measles outbreak in four health zones of the former Katanga Province, Democratic Republic of Congo.
    Keating P; Carrion Martin AI; Blake A; Lechevalier P; Uzzeni F; Gignoux E; Okonta C; Langendorf C; Smit S; Ahuka S; Suchard M; Pukuta E; Degail MA; Hansen L; Kibanza-Kyungu J; Ciglenecki I; Cohuet S
    BMC Public Health; 2019 Aug; 19(1):1153. PubMed ID: 31438898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].
    Xu A
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine-Derived Poliovirus Outbreaks and Events - Three Provinces, Democratic Republic of the Congo, 2017.
    Alleman MM; Chitale R; Burns CC; Iber J; Dybdahl-Sissoko N; Chen Q; Van Koko DR; Ewetola R; Riziki Y; Kavunga-Membo H; Dah C; Andriamihantanirina R
    MMWR Morb Mortal Wkly Rep; 2018 Mar; 67(10):300-305. PubMed ID: 29543791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring polio immunity to plan immunization activities.
    Voorman A; Lyons HM
    Vaccine; 2016 Nov; 34(48):5946-5952. PubMed ID: 27771181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.